Tag Archives: Michael Goldberg

Business, Finance, Occupation & Industry

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Incyte Corporation

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Incyte Corporation

LOS ANGELES–(BUSINESS WIRE)– Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of a class (the “Class”) comprising all purchasers of the common stock of Incyte Corporation (“Incyte” or the “Company”) (NAS: INCY) between April 26, 2012 and August 1, 2012 (the “Class Period“). The Complaint alleges that certain statements issued by Incyte during the Class Period were false and misleading regarding the Company’s business and financial prospects.

Incyte, a biopharmaceutical company, focuses on the discovery, development and commercialization of proprietary small molecule drugs for oncology and treatment of inflammation. The Complaint alleges that Incyte issued misleading statements concerning demand for the Company’s myelofibrosis drug, Jakafi.

On August 2, 2012, Incyte announced the Company’s second quarter 2012 financial results and disclosed that the sales growth of Jakafi had been much softer during the second quarter of 2012 than investors and certain stock analysts had been led to expect. In response to these disclosures, the price of Incyte stock declined 22% from its August 1, 2012 close of $24.92 per share, to close at $19.57 per share on August 2, 2012 on heavy trading volume.

No class has yet been certified in this action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased Incyte shares during the Class Period, you have certain rights and have until May 6, 2013 to move for lead plaintiff status. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice. If you wish to learn more or have any questions concerning your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, by telephone at (310) 201-9150, Toll Free at (888) 773-9224, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Binkow & Goldberg LLP, Los Angeles, CA
Michael Goldberg, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

KEYWORDS: …read more

Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit against Harvest Natural Resources Inc.

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit against Harvest Natural Resources Inc.

LOS ANGELES–(BUSINESS WIRE)– Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of Texas on behalf of a class (the “Class”) comprising all purchasers of the securities of Harvest Natural Resources Inc. (“Harvest” or the “Company”) (NYS: HNR) between May 7, 2010 and March 18, 2013.

Harvest, an independent energy company, engages in the acquisition, exploration, development, production and disposition of oil and natural gas properties. The Complaint alleges that throughout the Class Period defendants made false and/or misleading statements or failed to disclose material adverse facts about the Company’s financial performance and prospects. Specifically, defendants misrepresented or failed to disclose that: (1) the Company incorrectly capitalized certain lease maintenance costs and certain internal selling, general and administrative costs; (2) the Company improperly presented certain cash flow items and caused certain long-lived assets to be impaired; (3) the Company was unable to sell its interests in Petrodelta S.A. to PT Pertamina (Persero); (4) the Company lacked adequate internal and financial controls; and (5) as a result of the foregoing, the Company’s statements were materially false and misleading at all relevant times.

No class has yet been certified in this action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased Harvest securities during the Class Period, you have certain rights, and have until May 21, 2013 to move for lead plaintiff status. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice. If you wish to discuss this action or have any questions concerning your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, by telephone at (310) 201-9150, Toll Free at (888) 773-9224, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Binkow & Goldberg LLP
Michael Goldberg
(310) 201-9150 or (888) 773-9224
shareholders@glancylaw.com
www.glancylaw.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article Glancy Binkow & Goldberg …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against VeriFone Systems, Ltd.

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against VeriFone Systems, Ltd.

LOS ANGELES–(BUSINESS WIRE)– Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court, Northern District of California on behalf of all purchasers of the common stock of VeriFone Systems, Inc. (“VeriFone” or the “Company”) (NYS: PAY) between December 14, 2011 and February 19, 2013, inclusive (the “Class Period“).

VeriFone designs, markets, and services electronic payment solutions worldwide. The complaint alleges that: (a) the Company failed to execute its plan to move to a more subscriptions-based service model; (b) past acquisitions masked what was happening at the Company; (c) the Company’s accounting recognition was overly aggressive; (d) the Company lacked adequate internal and financial controls; and (e) as a result, the Company’s financial statements were materially false and misleading at all relevant times.

On February 20, 2013, the Company announced that it expected first quarter adjusted earnings to be between $0.47 to $0.57 per share on revenue of $424 million – well below analysts’ profit forecast of $0.73 per share on revenue of $492 million. The Company also announced a new revenue recognition policy which prevented it from recognizing revenues that quarter from distributors in the Middle East and Africa. On February 21, 2013, VeriFone shares declined $13.65 per share, or nearly 43%, to close on February 21, 2013, at $18.24 per share, on extremely heavy trading volume.

No class has yet been certified in this action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased VeriFone common stock during the Class Period, you have certain rights, and have until May 6, 2013 to move for lead plaintiff status. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice. If you wish to discuss this action or have any questions concerning your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, telephone: 310-201-9150, Toll-Free: 888-773-9224, e-mail: shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Binkow & Goldberg …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Glancy Binkow & Goldberg LLP Announces Investigation of Accretive Health, Inc.

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Glancy Binkow & Goldberg LLP Announces Investigation of Accretive Health, Inc.

LOS ANGELES–(BUSINESS WIRE)– Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of purchasers of the securities of Accretive Health, Inc. (“Accretive” or the “Company”) (NYS: AH) concerning possible violations of federal securities laws. The investigation focuses on allegations that certain statements issued by Accretive between May 9, 2012 and February 26, 2013 were false and misleading regarding the Company’s business, operations and prospects.

Accretive provides revenue cycle management services for hospitals and healthcare providers in the United States. The investigation is related to Accretive’s February 26, 2013 announcement that it will postpone the release of the Company’s financial results for the fourth quarter and full-year 2012 because it is evaluating the timing of revenue recognition for its revenue cycle management agreements. In addition, Accretive announced that it was withdrawing the financial guidance that the Company previously provided on November 7, 2012. As a result of this news, the price of Accretive shares declined almost 20%, on heavy trading volume.

If you purchased Accretive securities between May 9, 2012 and February 26, 2013, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, by telephone at (310) 201-9150, Toll Free at (888) 773-9224, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Binkow & Goldberg LLP
Michael Goldberg
(310) 201-9150 or (888) 773-9224
shareholders@glancylaw.com
www.glancylaw.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article Glancy Binkow & Goldberg LLP Announces Investigation of Accretive Health, Inc. originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley …read more
Source: FULL ARTICLE at DailyFinance